REG-BARCLAYS PLC Form 8.3 - Willis Towers Watson plc
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201111:nBw7xyywxa
Form 8.3 - Willis Towers Watson plc
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 10 November 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,168,008 2.46% 687,185 0.53%
(2) Derivatives (other than options):
366,484 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,534,492 2.74% 1,426,190 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 200.4100 USD
Purchase 3 199.9100 USD
Purchase 8 200.0500 USD
Purchase 19 199.8905 USD
Purchase 24 200.3935 USD
Purchase 36 200.3983 USD
Purchase 40 200.5700 USD
Purchase 44 198.3661 USD
Purchase 67 201.3437 USD
Purchase 100 202.2500 USD
Purchase 100 200.4400 USD
Purchase 100 200.3700 USD
Purchase 100 202.2200 USD
Purchase 132 200.2995 USD
Purchase 200 200.5850 USD
Purchase 201 201.4006 USD
Purchase 209 196.3700 USD
Purchase 215 198.7131 USD
Purchase 235 200.4597 USD
Purchase 251 198.7188 USD
Purchase 254 200.5594 USD
Purchase 300 200.4974 USD
Purchase 493 200.3673 USD
Purchase 520 200.2108 USD
Purchase 532 200.4962 USD
Purchase 769 199.8893 USD
Purchase 900 202.1400 USD
Purchase 1,158 200.4758 USD
Purchase 1,751 199.5451 USD
Purchase 1,755 199.5507 USD
Purchase 1,830 200.2880 USD
Purchase 2,336 200.4854 USD
Purchase 2,946 202.0100 USD
Purchase 3,214 198.8790 USD
Purchase 3,493 200.4009 USD
Purchase 4,594 199.2406 USD
Purchase 4,909 201.4965 USD
Purchase 5,154 199.5457 USD
Purchase 5,903 200.4094 USD
Purchase 23,523 200.5974 USD
Purchase 29,892 200.3379 USD
Purchase 49,237 199.7642 USD
Sale 1 200.1700 USD
Sale 2 199.0650 USD
Sale 3 199.9100 USD
Sale 4 199.7850 USD
Sale 5 200.4000 USD
Sale 39 198.1053 USD
Sale 40 200.5700 USD
Sale 43 198.3300 USD
Sale 130 201.9826 USD
Sale 200 197.7300 USD
Sale 300 202.1600 USD
Sale 571 200.0284 USD
Sale 900 201.7994 USD
Sale 900 201.5166 USD
Sale 1,058 200.3307 USD
Sale 1,100 199.1781 USD
Sale 1,440 199.5234 USD
Sale 1,731 199.4089 USD
Sale 3,265 198.9371 USD
Sale 3,851 202.0100 USD
Sale 5,043 201.3619 USD
Sale 10,000 200.4358 USD
Sale 27,849 200.3598 USD
Sale 89,902 199.9867 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 11 Nov 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201111005388/en/
(https://www.businesswire.com/news/home/20201111005388/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC Unite Group PLC - Form 8.3 - UNITE GROUP PLC, THE Replacement
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC Replacement
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC Replacement
AnnouncementREG - Barclays PLC Dowlais Group PLC - Form 8.5 EPT/Non RI DOWLAIS GROUP PLC Replacement
AnnouncementREG - Barclays PLC Bakkavor Group PLC - Form 8.3 BAKKAVOR GROUP PLC Replacement
Announcement